Valthos is an applied biological intelligence company founded in 2024. It develops frontier AI systems aimed at identifying biological threats and designing medical countermeasures in real time. The company operates at the intersection of artificial intelligence, biotechnology, and computational biology, serving sectors including biodefense, public health, and national security.
Its core platform ingests biological data from government and commercial sources - such as air and wastewater monitoring - to identify emerging threats, assess risks, and analyze biological sequences. The system is designed to adapt existing medicines in response to pathogens, with the stated goal of shrinking response times from months to hours.
The founding team includes personnel from Palantir, DeepMind, MIT's Broad Institute, and the Arc Institute. The company has raised $30 million in funding.
